Many renal units still fail to return blood pressure data to the Renal Registry. In England, Northern Ireland and Wales, the percentage of HD patients achieving the combined blood pressure standard (<140/90 predialysis) averages 43% (inter unit range 16-60%) and post-dialysis (<130/80) average 48% (range 22-66%). On average 27% (range 12-48%) of PD patients achieve the standard of <130/80 and 26% of renal transplant patients (range 16-40%). Over the last 8 years there has been no significant change in systolic or diastolic blood pressure achievement. Better comorbidity data returns are required by the Registry to perform blood pressure survival analyses.
Introduction
International and UK blood pressure guidelines [1, 2, 3, 4] recommend a target blood pressure below 130/80 mmHg for patients with chronic kidney disease (CKD), diabetes and established atherosclerosis. The intention is to reduce cardiovascular complications and progression to renal failure. So far, clinical trials involving CKD patients have all been designed to assess low blood pressure on renal progression as the primary endpoint. Cardiovascular data from these trials are inconclusive and were reviewed in some detail in last year's report. Blood pressure guidelines take no account of epidemiological data that describe a U-shaped relationship between baseline systolic blood pressure (SBP) and 1 year mortality. Several reports show higher cardiovascular mortality for haemodialysis patients with baseline pre-and post-SBP <110 mmHg [5, 6] . The UK Renal Registry has also shown increased all-cause mortality at 1 year for incident haemodialysis patients with baseline preand post-SBP <120 mmHg [7] . This raises concern that achieving lower blood pressure targets may be detrimental for some dialysis patients. In 2006, two studies of USA haemodialysis patients analysed the changing relationship of blood pressure with mortality over several years. In the first, hazard ratios for 3-year all-cause mortality for 56 338 incident patients were 2.5 for a baseline SBP <120 mmHg and 1.4 for baseline SBP 120-139 mmHg [8] . Hazard ratios were 5.5 and 1.9, respectively when blood pressure variability was included in the analysis. In the second study [9] the hazard ratio for 2 year all-cause mortality for 16 959 incident patients was 1.7 for baseline SBP 110-119 mmHg. Interestingly, the hazard ratio fell to 0.8 and 0.7 for the third and fourth year, respectively. This is the first data to suggest that achieving low blood pressure guidelines may be beneficial for dialysis patients. In the same study a baseline SBP >170 mmHg was only associated with increased all-cause mortality after 3 years. Intuitively one would expect early deaths to affect patients with established heart failure as hypertension precedes cardiac failure by many years but neither study included comorbidity data to delineate causal associations. Finally, data from the Irbesartan Diabetic Nephropathy Trial [10] showed improved renal function and patient survival down to a SBP of 120 mmHg. Below this, all-cause mortality increased (relative risk 1.25) for both patients with and without pre-existing cardiovascular disease. It will be difficult to prove whether low blood pressure may be beneficial as poor health is a common confounding factor in renal patients.
Last year less than one-third of patients on RRT in England and Wales achieved the blood pressure standard. However, the renal unit at York consistently achieves the best blood pressure results across all treatment modalities suggesting a rational approach to monitoring and therapy. Their patients are sent to a dietician for salt restriction initially. Then patients achieve dry weight by ultrafiltration or diuretics.
Finally, antihypertensive medication is increased. Several publications in the last year support this strategy. An audit of 469 prevalent haemodialysis patients dialysing in seven different centres in the UK compared blood pressure control with varying dialysate sodium concentration [11] . All patients were advised to restrict salt intake to 5 g/day. Patients dialysing with sodium concentration 137-139 mmol/l had significantly lower pre-and post-SBP compared to those dialysed against 140 mmol/l. They also had lower interdialytic weight gains and were prescribed fewer antihypertensive drugs. Intradialytic hypotension correlated with age rather than dialysate sodium concentration. Similarly, a prospective study of 46 prevalent peritoneal dialysis patients in Turkey showed reduced salt intake and use of hypertonic solutions could maintain blood pressure below 130/85 mmHg over a 2-year period without antihypertensive medication [12] . Left ventricular hypertrophy was detected in only 8% of patients after 2 years. No patient lost residual renal function, ultrafiltration rate or dialysis adequacy during the study. The published evidence suggests salt and water balance is important to achieve blood pressure standards in dialysis patients.
Blood pressure control
The RA standards for control of hypertension were established in August 2002:
Pre-haemodialysis blood pressure <140/90 mmHg. Post-haemodialysis, peritoneal dialysis and renal transplant blood pressure <130/80 mmHg.
Methods
The Registry extracts quarterly blood pressure data electronically from UK renal units. 
Results

Data returns
Poor returns (<50%) were obtained from 20 centres for HD data, 31 centres for PD data and 35 centres for Tx data ( The median blood pressure pre-HD, post-HD, PD and Tx is 143/75, 128/69, 136/80 and 136/79 mmHg. Median PP for each group is 66, 59, 57 and 57 mmHg, respectively. The HD population has the widest spread for blood pressure. Standard deviations (SBP/DBP) pre-HD, post-HD, PD and Tx are 26/15, 25/14, 23/13 and 19/11, respectively. This compares to 18/10 for a hypertensive population. Last year in a single centre study of 317 prevalent HD patients, the Registry showed blood pressure was significantly higher at the start of the dialysis week. The wider blood pressure distribution for HD may partially therefore reflect the random timing of readings and influence of fluid overload.
Achievement of combined systolic and diastolic standard
Figures 10.4-10.7 show a wide variation between renal units achieving the combined blood pressure standard for each modality. In England, Northern Ireland and Wales, the percentage of HD patients achieving the standard pre-dialysis averages 43% (range over renal units 16-60%) and post-dialysis averages 48% (range 22-66%). Only 27% of PD patients (range 12-48%) and 26% of Tx patients (range 16-40%) achieve the standard. Chi squared testing indicates the variation between centres for HD and Tx is significant (P < 0.001) but not for PD. The variation between nations is also significant for HD and Tx (P 0.008) but not for PD. The results are similar to last year and show control of hypertension remains inadequate across all treatment modalities but is significantly better in the HD population. National results have been highlighted in boldface. In England, Northern Ireland and Wales, the percentage of HD patients achieving the standard pre-dialysis averages 72% (range 43-89%) and post-dialysis averages 69% (range 43-80%). On average 48% of PD patients (range 32-68%) and 48% of Tx patients (range 34-74%) achieve the standard. Chi squared testing indicates that there is significant variation between centres for HD and Tx (P < 0.001). The variation is less marked for PD and is only of borderline significance (P ¼ 0.052). The variation between nations is significant for pre-HD (P ¼ 0.001) and Tx (P < 0.001) but not for post-HD or PD. The median MAP for pre-HD, post-HD, PD and Tx is 98, 89, 98 and 97 mmHg, respectively. 70  75  80  85  90  95  100  105  110  115  120 7 Diabetics have the poorest blood pressure control of all the diagnostic groups. While salt intake correlates with water intake in non-diabetics, hyperglycaemia accounts for 50% of water intake by diabetics on HD [13] so may exacerbate hypertension. Blood pressure control is significantly better on HD for all diagnostic groups (P < 0.0001 for all groups). Combining groups, the percentage of patients achieving the BP standard on HD compared to PD or Tx are 42% vs 24% for macrovascular disease, 49% vs 26% for glomerulonephritis and 53% vs 26% for tubular disorders (P < 0.0001 for each comparison). This may be due to more frequent monitoring and intervention in the HD population. If so, nephrologists will need to devise more effective strategies for monitoring blood pressure control in out-patient populations.
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Future direction
The UK Renal Registry needs improved returns of comorbidity data for each patient to perform adjusted survival analyses. The question of whether achieving blood pressure standards is beneficial for all patients receiving RRT can then be addressed. The Registry requests that blood pressure data is logged every 
Factors influencing cardiovascular disease vii135
Where data on a patient are submitted from more than one centre, only data from the primary centre are used.
Qtemp
Further exclusion criteria applied to Qtemp to create data set called Quarter. Patients who had died by the end of the quarter. Patients who were lost to follow up by the end of the quarter.
Quarter
Further exclusion criteria applied to quarter to create data set called Bichem.
Exclusion criteria are:
Patients who had been on ERF treatment for 90 days at the end of the quarter.
Patients who changed treatment modality in the quarter.
Patients who transferred into the centre (qhcent) at some time in the quarter.
